References
- Murdoch IE, Morris SS, Cousens SN. People and eyes: statistical approaches in ophthalmology. Br J Ophthalmol 1998;82:971–973.
- Armstrong RA. Statistical guidelines for the analysis of data obtained from one or both eyes. Ophthalmic Physiol Optics 2013;33:7–14.
- Laird NM, Ware JH. Random-effects models for longitudinal data. Biometrics 1982;38:963–974.
- Liang KY, Zeger SL. Longitudinal data analysis using generalized linear models. Biometrika 1986;73:13–22.
- Liang KY, Zeger SL. Regression analysis for correlated data. Annu Rev Pub Health 1993;14:43–68.
- The Comparison of Age-related Macular Degeneration Treatments Trials Research Group. Ranibizumab and bevacizumab for neovascular age-related macular degeneration. N Engl J Med 2011;364:1897–1908.
- Glynn RJ, Rosner B. Regression methods when the eye is the unit of analysis. Ophthalmic Epidemiol 2012;19:159–165.
- Glynn RJ, Seddon JM, Krug JH Jr,et al.Falls in elderly patients with glaucoma. Arch Ophthalmol 1991;109:205–210.
- Hubbard AE, Ahern J, Fleischer NL, et al. To GEE or not to GEE. Comparing population average and mixed models for estimating the associations between neighborhood risk factors and health. Epidemiology 2010;21:467–474.
- Gardiner JC, Luo ZH, Roman LA. Fixed effects, random effects and GEE: what are the differences? Stat Med 2009;28:221–239.